- Home
- ELAB vs XYLO Comparison
ELAB vs XYLO Comparison
Compare ELAB & XYLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELAB
- XYLO
- Stock Information
- Founded
- ELAB 2020
- XYLO 1999
- Country
- ELAB United States
- XYLO Israel
- Employees
- ELAB N/A
- XYLO N/A
- Industry
- ELAB
- XYLO
- Sector
- ELAB
- XYLO
- Exchange
- ELAB Nasdaq
- XYLO NYSE
- Market Cap
- ELAB 6.6M
- XYLO 6.1M
- IPO Year
- ELAB 2023
- XYLO N/A
- Fundamental
- Price
- ELAB $2.16
- XYLO $5.18
- Analyst Decision
- ELAB
- XYLO
- Analyst Count
- ELAB 0
- XYLO 0
- Target Price
- ELAB N/A
- XYLO N/A
- AVG Volume (30 Days)
- ELAB 1.5M
- XYLO 3.0K
- Earning Date
- ELAB 08-13-2025
- XYLO 07-07-2025
- Dividend Yield
- ELAB N/A
- XYLO N/A
- EPS Growth
- ELAB N/A
- XYLO N/A
- EPS
- ELAB N/A
- XYLO N/A
- Revenue
- ELAB N/A
- XYLO $29,858,000.00
- Revenue This Year
- ELAB N/A
- XYLO $279.19
- Revenue Next Year
- ELAB N/A
- XYLO N/A
- P/E Ratio
- ELAB N/A
- XYLO N/A
- Revenue Growth
- ELAB N/A
- XYLO N/A
- 52 Week Low
- ELAB $1.95
- XYLO $2.70
- 52 Week High
- ELAB $840.00
- XYLO $6.67
- Technical
- Relative Strength Index (RSI)
- ELAB 45.40
- XYLO 54.95
- Support Level
- ELAB $1.96
- XYLO $4.85
- Resistance Level
- ELAB $2.26
- XYLO $5.18
- Average True Range (ATR)
- ELAB 0.22
- XYLO 0.20
- MACD
- ELAB 0.03
- XYLO 0.02
- Stochastic Oscillator
- ELAB 17.95
- XYLO 92.00
About ELAB Elevai Labs Inc.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
About XYLO XYLO TECHNOLOGIES LTD
Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in four segments are: Corporate, Online advertising & internet traffic routing, Online event management, real-estate and electronics. The company's geographical segments include USA, Europe, Great Britain, Israel, Canada, Asia and others.